Zhu’s current research includes studying host-microbiota metabolic interactions and the critical roles of nutritional components in modulating such interactions, as well as investigating the impact of therapeutic modulation of gut microbes to colorectal cancer patients. He is also developing multiplex mass spectrometry-based metabolomics platforms for various disease diagnosis and treatment monitoring studies. His lab is well-funded by the National Institutes of Health, the United States Department of Agriculture, and The Intelligence Advanced Research Projects Activity. He earned a BS and MS from Donghua University, Shanghai, China, and a PhD from the University of Vermont.